1247P Management of infusion-related reactions (IRRs) in patients receiving amivantamab

Park, K., Sabari, J. K., Haura, E. B., Shu, C. A., Spira, A., Salgia, R., Reckamp, K. L., Sanborn, R. E., Govindan, R., Bauml, J. M., Curtin, J. C., Xie, J., Roshak, A., Lorenzini, P., Millington, D., Thayu, M., Knoblauch, R. E., & Cho, B. C. (2021). 1247P Management of infusion-related reactions (IRRs) in patients receiving amivantamab. Annals of Oncology, 32, S981–S982. https://doi.org/10.1016/j.annonc.2021.08.1852
Authors:
K. Park
Joshua K. Sabari
Eric B. Haura
Catherine A. Shu
Alexander I. Spira
Ravi Salgia
Karen L. Reckamp
Rachel E. Sanborn
Ramaswamy Govindan
Joshua Bauml
Joshua C. Curtin
John Xie
Amy Roshak
Patricia Lorenzini
Dawn Millington
Meena Thayu
R.E. Knoblauch
Byoung Chul Cho
Affiliated Authors:
Catherine A. Shu
Columbia Affiliation:
Subjects:
Advancements in Lung Cancer Research (OpenAlex Topic)
Advancements in Colorectal Cancer Research (OpenAlex Topic)
Hepatocellular Carcinoma (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1016/j.annonc.2021.08.1852
DOI:
10.1016/j.annonc.2021.08.1852
Journal:
Annals of Oncology
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: